This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosanò, L. Articles by Bagnato, A. Search for Related Content PubMed PubMed Citation Articles by Rosanò, L. Articles by Bagnato, A.

Endothelin-1 Promotes Epithelial-to-Mesenchymal Transition in Human Ovarian Cancer Cells

¹ Laboratory of Molecular Pathology and Ultrastructure, Regina Elena Cancer Institute; ² Molecular Biology and Pathology Institute, National Research Council, Rome, Italy; ³ British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada; and ⁴ Unitat de Biologia Cellular i Molecular, Institut Municipal d'Investigació Mèdica, Universitat Pompeu Fabra, Barcelona, Spain

Requests for reprints: Anna Bagnato, Laboratory of Molecular Pathology and Ultrastructure, Regina Elena Cancer Institute, Via delle Messi D'Oro 156, 00158 Rome, Italy. Phone: 39-06-5266-2565; Fax: 39-06-5266-2600; E-mail: bagnato{at}ifo.it.

Despite considerable efforts to improve early detection and advances in chemotherapy, metastatic relapses remain a major challenge in the management of ovarian cancer. The endothelin A receptor (ET_AR)/endothelin-1 (ET-1) axis has been shown to have a significant role in ovarian carcinoma by promoting tumorigenesis. Here we show that the ET-1/ET_AR autocrine pathway drives epithelial-to-mesenchymal transition (EMT) in ovarian tumor cells by inducing a fibroblastoid and invasive phenotype, down-regulation of E-cadherin, increased levels of ß-catenin, Snail, and other mesenchymal markers, and suppression of E-cadherin promoter activity. Activation of ET_AR by ET-1 triggers an integrin-linked kinase (ILK)–mediated signaling pathway leading to glycogen synthase kinase-3ß (GSK-3ß) inhibition, Snail and ß-catenin stabilization, and regulation of transcriptional programs that control EMT. Transfection of dominant negative ILK or exposure to an ILK inhibitor suppresses the ET-1-induced phosphorylation of GSK-3ß as well as Snail and ß-catenin protein stability, activity, and invasiveness, indicating that ET-1/ET_AR–induced EMT-promoting effects depend on ILK. ET_AR blockade by specific antagonists or reduction by ET_AR RNA interference reverses EMT and cell invasion by inhibiting autocrine signaling pathways. In ovarian carcinoma xenografts, ABT-627, a specific ET_AR antagonist, suppresses EMT determinants and tumor growth. In human ovarian cancers, ET_AR expression is associated with E-cadherin down-regulation, N-cadherin expression, and tumor grade. Collectively, these findings provide evidence of a critical role for the ET-1/ET_AR axis during distinct steps of ovarian carcinoma progression and identify novel targets of therapeutic intervention. (Cancer Res 2005; 65(24): 11649-57)

This article has been cited by other articles:

				G. V. Shah, A. Muralidharan, M. Gokulgandhi, K. Soan, and S. Thomas Cadherin Switching and Activation of {beta}-Catenin Signaling Underlie Proinvasive Actions of Calcitonin-Calcitonin Receptor Axis in Prostate Cancer J. Biol. Chem., January 9, 2009; 284(2): 1018 - 1030. [Abstract] [Full Text] [PDF]

				P. C. McDonald, A. B. Fielding, and S. Dedhar Integrin-linked kinase - essential roles in physiology and cancer biology J. Cell Sci., October 1, 2008; 121(19): 3121 - 3132. [Abstract] [Full Text] [PDF]

				E. I. Ager, J. Neo, and C. Christophi The renin-angiotensin system and malignancy Carcinogenesis, September 1, 2008; 29(9): 1675 - 1684. [Abstract] [Full Text] [PDF]

				Y. L. Pon, H. Y. Zhou, A. N.Y. Cheung, H. Y.S. Ngan, and A. S.T. Wong p70 S6 Kinase Promotes Epithelial to Mesenchymal Transition through Snail Induction in Ovarian Cancer Cells Cancer Res., August 15, 2008; 68(16): 6524 - 6532. [Abstract] [Full Text] [PDF]

				T.-V. Do, L. A. Kubba, M. Antenos, A. W. Rademaker, C. D. Sturgis, and T. K. Woodruff The Role of Activin A and Akt/GSK Signaling in Ovarian Tumor Biology Endocrinology, August 1, 2008; 149(8): 3809 - 3816. [Abstract] [Full Text] [PDF]

				M. Iribarne, L. Ogawa, V. Torbidoni, C. M. Dodds, R. A. Dodds, and A. M. Suburo Blockade of Endothelinergic Receptors Prevents Development of Proliferative Vitreoretinopathy in Mice Am. J. Pathol., April 1, 2008; 172(4): 1030 - 1042. [Abstract] [Full Text] [PDF]

				S. Shell, S.-M. Park, A. R. Radjabi, R. Schickel, E. O. Kistner, D. A. Jewell, C. Feig, E. Lengyel, and M. E. Peter Let-7 expression defines two differentiation stages of cancer PNAS, July 3, 2007; 104(27): 11400 - 11405. [Abstract] [Full Text] [PDF]

				L. Rosano, V. Di Castro, F. Spinella, G. Tortora, M. R. Nicotra, P. G. Natali, and A. Bagnato Combined Targeting of Endothelin A Receptor and Epidermal Growth Factor Receptor in Ovarian Cancer Shows Enhanced Antitumor Activity Cancer Res., July 1, 2007; 67(13): 6351 - 6359. [Abstract] [Full Text] [PDF]

				R. Jain, P. W. Shaul, Z. Borok, and B. C. Willis Endothelin-1 Induces Alveolar Epithelial-Mesenchymal Transition through Endothelin Type A Receptor-Mediated Production of TGF-beta1 Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 38 - 47. [Abstract] [Full Text] [PDF]

				L. Rosano, V. Di Castro, F. Spinella, M. R. Nicotra, P. G. Natali, and A. Bagnato ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo Mol. Cancer Ther., July 1, 2007; 6(7): 2003 - 2011. [Abstract] [Full Text] [PDF]

				M J Grimshaw Endothelins and hypoxia-inducible factor in cancer Endocr. Relat. Cancer, June 1, 2007; 14(2): 233 - 244. [Abstract] [Full Text] [PDF]

				S. Banerjee, M. Hussain, Z. Wang, A. Saliganan, M. Che, D. Bonfil, M. Cher, and F. H. Sarkar In vitro and In vivo Molecular Evidence for Better Therapeutic Efficacy of ABT-627 and Taxotere Combination in Prostate Cancer Cancer Res., April 15, 2007; 67(8): 3818 - 3826. [Abstract] [Full Text] [PDF]

				G. A. Clines, K. S. Mohammad, Y. Bao, O. W. Stephens, L. J. Suva, J. D. Shaughnessy Jr., J. W. Fox, J. M. Chirgwin, and T. A. Guise Dickkopf Homolog 1 Mediates Endothelin-1-Stimulated New Bone Formation Mol. Endocrinol., February 1, 2007; 21(2): 486 - 498. [Abstract] [Full Text] [PDF]

				B. Davidson, Z. Zhang, L. Kleinberg, M. Li, V. A. Florenes, T.-L. Wang, and I.-M. Shih Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma. Clin. Cancer Res., October 15, 2006; 12(20): 5944 - 5950. [Abstract] [Full Text] [PDF]

				F. Spinella, L. Rosano, V. Di Castro, S. Decandia, A. Albini, M. R. Nicotra, P. G. Natali, and A. Bagnato Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol. Cancer Ther., June 1, 2006; 5(6): 1483 - 1492. [Abstract] [Full Text] [PDF]

				L. Rosano, F. Spinella, V. Di Castro, S. Dedhar, M. R. Nicotra, P. G. Natali, and A. Bagnato Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Mol. Cancer Ther., April 1, 2006; 5(4): 833 - 842. [Abstract] [Full Text] [PDF]